Privigen Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
Conditions:   Primary Immune Deficiency;   Secondary Immune DeficiencyIntervention:   Biological: Subcutaneous Immune Globulin (Human) (Hizentra)Sponsor:   CSL BehringRecruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2016 Category: Research Source Type: clinical trials